Tenet Healthcare (THC) Scheduled to Post Earnings on Tuesday

Tenet Healthcare (NYSE:THC) is scheduled to post its quarterly earnings results before the market opens on Tuesday, April 30th. Analysts expect Tenet Healthcare to post earnings of $1.41 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, February 8th. The company reported $2.68 EPS for the quarter, topping the consensus estimate of $1.58 by $1.10. Tenet Healthcare had a return on equity of 26.34% and a net margin of 2.97%. The company had revenue of $5.38 billion during the quarter, compared to analyst estimates of $5.28 billion. During the same period in the previous year, the business earned $1.96 EPS. Tenet Healthcare’s quarterly revenue was up 7.8% on a year-over-year basis. On average, analysts expect Tenet Healthcare to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Tenet Healthcare Trading Down 1.4 %

THC opened at $96.13 on Monday. Tenet Healthcare has a one year low of $51.04 and a one year high of $107.80. The stock has a market capitalization of $9.54 billion, a PE ratio of 16.84, a P/E/G ratio of 3.08 and a beta of 2.08. The business’s 50 day moving average price is $98.22 and its 200 day moving average price is $80.71. The company has a debt-to-equity ratio of 4.77, a quick ratio of 1.42 and a current ratio of 1.51.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on THC. Barclays assumed coverage on shares of Tenet Healthcare in a research report on Wednesday, March 6th. They set an “overweight” rating and a $113.00 price target for the company. Royal Bank of Canada boosted their price objective on shares of Tenet Healthcare from $97.00 to $109.00 and gave the company an “outperform” rating in a research note on Friday, February 9th. Wolfe Research upgraded shares of Tenet Healthcare from a “peer perform” rating to an “outperform” rating and set a $122.00 price objective on the stock in a report on Wednesday, March 27th. TheStreet raised shares of Tenet Healthcare from a “c+” rating to a “b-” rating in a research report on Tuesday, February 6th. Finally, Mizuho upped their target price on shares of Tenet Healthcare from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. One research analyst has rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $100.38.

Insider Buying and Selling

In related news, EVP Thomas W. Arnst sold 17,000 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $94.84, for a total value of $1,612,280.00. Following the completion of the transaction, the executive vice president now directly owns 8,148 shares of the company’s stock, valued at approximately $772,756.32. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Richard W. Fisher sold 2,100 shares of the firm’s stock in a transaction on Wednesday, February 14th. The shares were sold at an average price of $88.21, for a total transaction of $185,241.00. Following the sale, the director now owns 20,127 shares in the company, valued at approximately $1,775,402.67. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Thomas W. Arnst sold 17,000 shares of Tenet Healthcare stock in a transaction on Friday, March 1st. The stock was sold at an average price of $94.84, for a total transaction of $1,612,280.00. Following the completion of the transaction, the executive vice president now owns 8,148 shares in the company, valued at approximately $772,756.32. The disclosure for this sale can be found here. In the last ninety days, insiders sold 51,268 shares of company stock valued at $4,944,810. Company insiders own 0.93% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.